Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).

作者: Liza Solomon , Michael Stein , Colin Flynn , Paula Schuman , Ellie Schoenbaum

DOI: 10.1097/00042560-199803010-00011

关键词: SidaDemographyOutpatient clinicPublic healthOpportunistic infectionImmunologyEpidemiologyAsymptomaticMedicineEmergency departmentAcquired immunodeficiency syndrome (AIDS)

摘要: OBJECTIVE To characterize health services use by urban women with or at risk for HIV-1 infection enrolled in a prospective multicenter study. METHODS 1310 16 to 55 years of age who were recruited between April 1993 and January 1995 four centers (Baltimore, Maryland; The Bronx, New York; Detroit, Michigan; Providence, Rhode Island). HIV-1-seropositive without AIDS-defining illness oversampled ratio 2:1 comparison HIV-1-seronegative women. At baseline study visit, the received physical laboratory examinations, including CD4+ counts, interviewed regarding HIV behavior, use, clinical data. RESULTS 863 430 HIV-1-seronegative. Fifty-two percent reported injection drug (IDU) since 1985, 48% acquired through sexual contact. Seventy-seven African American, 23% white, 16% Hispanic. median was 35 years. HIV-seronegative significantly less likely have insurance (19%) than HIV-seropositive (30%; p < .001). Among women, 68% had cell counts <500/microl, 64% asymptomatic. Sixty-four an outpatient hospital visit past 6 months, as 86% (p 0.001). Hospitalization months also higher (22% vs. 12%; Despite heavy services, only 49% <200/microl current antiretroviral therapy, 58% Pneumocystis carinii pneumonia (PCP) prophylaxis. after adjusting count, symptoms, race, site, IDUs regular doctor recent more be hospitalized emergency department (ED) non-IDUs. In multivariate analyses persons, American similar access care therapy PCP prophylaxis did white but previous taking opportunistic (OI) Health HIV-related therapies not differ Hispanic infection. CONCLUSION Although both high levels medical antiretrovirals OI low throughout, used primary receive episodic care. IDU race independently associated decreased services.

参考文章(14)
U. Sambamoorthi, Stephen Crystal, C. Merzel, The diffusion of innovation in AIDS treatment: Zidovudine use in two New Jersey cohorts Health Services Research. ,vol. 30, pp. 593- 614 ,(1995)
J Piette, V Mor, J Fleishman, Patterns of survival with AIDS in the United States. Health Services Research. ,vol. 26, pp. 75- 95 ,(1991)
F J Hellinger, The use of health services by women with HIV infection. Health Services Research. ,vol. 28, pp. 543- 561 ,(1993)
Richard D. Moore, Julia Hidalgo, Barbara W. Sugland, Richard E. Chaisson, Zidovudine and the Natural History of the Acquired Immunodeficiency Syndrome New England Journal of Medicine. ,vol. 324, pp. 1412- 1416 ,(1991) , 10.1056/NEJM199105163242006
Michael D. Stein, John Piette, Vincent Mor, Tom J. Wachtel, John Fleishman, Kenneth H. Mayer, Charles C. J. Carpenter, Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons Journal of General Internal Medicine. ,vol. 6, pp. 35- 40 ,(1991) , 10.1007/BF02599388
Barbara J. Turner, Leona E. Markson, Linda J. McKee, Robert Houchens, Thomas Fanning, Health care delivery, zidovudine use, and survival of women and men with AIDS. Journal of Acquired Immune Deficiency Syndromes. ,vol. 7, pp. 1250- 1262 ,(1994) , 10.1097/00126334-199412000-00006
D. K. Smith, D. L. Warren, D. Vlahov, P. Schuman, M. D. Stein, B. L. Greenberg, S. D. Holmberg, , Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. American Journal of Epidemiology. ,vol. 146, pp. 459- 469 ,(1997) , 10.1093/OXFORDJOURNALS.AJE.A009299
J D Piette, V Mor, K Mayer, S Zierler, T Wachtel, The effects of immune status and race on health service use among people with HIV disease. American Journal of Public Health. ,vol. 83, pp. 510- 514 ,(1993) , 10.2105/AJPH.83.4.510
Richard M Selik, Susan Y Chu, James W Buehler, HIV Infection as Leading Cause of Death Among Young Adults in US Cities and States JAMA: The Journal of the American Medical Association. ,vol. 269, pp. 2991- 2994 ,(1993) , 10.1001/JAMA.1993.03500230073032
L Solomon, R Frank, D Vlahov, J Astemborski, Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal of Public Health. ,vol. 81, pp. 1285- 1290 ,(1991) , 10.2105/AJPH.81.10.1285